Portal de Periódicos da CAPES

Doxorubicin compared with related compounds in a nude mouse model for human ovarian cancer

1990; Pergamon Press; Volume: 26; Issue: 9 Linguagem: Inglês

10.1016/0277-5379(90)90626-5

1878-5980

Epie Boven, Hennie M.M. Schlüper, Caroline A.M. Erkelens, Herbert M. Pinedo,

Cancer Treatment and Pharmacology

Eight human ovarian cancer lines grown in nude mice were used to compare the activity of doxorubicin, epirubicin, mitoxantrone and menogaril. The tumour lines were different in histological subtype, tumour doubling time and sensitivity to doxorubicin. The compounds were administered intravenously at the maximum tolerated dose twice with one week in between when tumours measured 50–150 mm3. Growth inhibition greater than 50% was obtained for doxorubicin in 88, for epirubicin in 48, for mitoxantrone in 58 and for menogaril in 28 tumour lines. In MRI-H-207, doxorubicin was the only drug able to induce complete remission. Compared with doxorubicin, mitoxantrone and menogaril were given in proportionally higher doses than those administered to patients, but did not result in superior antitumour activity.